The prevalence of diabetes is increasing worldwide; however, its impact on routine daily activities is often underappreciated ...

In a major positive step for global respiratory health, Member States at the 78th World Health Assembly (WHA), held May 19–27 ...

Market Growth Driven by Declining Sequencing Costs, Rising Prevalence of Neurological Disorders, Advanced Sequencing ...

A punch biopsy reliably detected a biomarker of neurodegenerative disease in a small cohort of older adults diagnosed with idiopathic REM sleep disorder, according to a poster presented at SLEEP ...

Nemanja Matic has been given a four-match ban after covering an anti-homophobia logo on his shirt while playing for Lyon. The incident occurred when Lyon beat Angers 2-0 in the 34th and final ...

RFK Jr. says he may bar scientists from publishing in top medical journals Health Secretary Robert F. Kennedy Jr. took aim at reputed journals such as the Lancet and said his agency will create ...

Logo após o início da guerra, exatamente há 100 anos, houve uma “epidemia” de sintomas neurológicos conversivos. Soldados de ambos os lados começaram a apresentar com frequência sintomas neurológicos, ...

A purple dragon dressed in a business suit seemed like a natural choice for a logo when Jacob A. Perrone, a lawyer in East Lansing, Mich., recently opened a new firm and named it Dragon Lawyers.

In the 2010 Journal Citation Reports, The Lancet s impact factor was ranked second among general medical journals, at 33.63, after The New England Journal of Medicine (53.48).

The scientists dug into the data from three studies, ESCAPE-NA1, ESCAPE-NEXT and FRONTIER trials, and re-examined the results in a meta-analysis paper published this week in The Lancet Neurology.

The latest study results have been published online in the renowned "The Lancet Neurology" journal. A multi-centre clinical trial (NISCI trial: Nogo-A Inhibition in acute Spinal Cord Injury Study ...

Novel synSAA Advances Diagnostic Accuracy for Multiple System Atrophy and Related Disorders SAN DIEGO-- (BUSINESS WIRE)-- Amprion, a global leader advancing diagnosis of neurodegenerative disorders ...